Compare RCKY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKY | LAB |
|---|---|---|
| Founded | 1932 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.5M | 326.2M |
| IPO Year | 1996 | 2008 |
| Metric | RCKY | LAB |
|---|---|---|
| Price | $46.79 | $0.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | $1.35 |
| AVG Volume (30 Days) | 61.3K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 94.74 | 61.54 |
| EPS | ★ 1.99 | 0.26 |
| Revenue | ★ $270,408,000.00 | $101,937,000.00 |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $4.90 | $2.63 |
| P/E Ratio | $23.31 | ★ $2.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.30 | $0.63 |
| 52 Week High | $53.01 | $1.72 |
| Indicator | RCKY | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 38.50 |
| Support Level | $38.26 | N/A |
| Resistance Level | $48.70 | $0.99 |
| Average True Range (ATR) | 1.58 | 0.05 |
| MACD | -0.51 | -0.01 |
| Stochastic Oscillator | 15.86 | 22.82 |
Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.